Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9207
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 131 $2,359,670 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $2,359,670 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 47% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award SPE2DR25D9207 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999 single-award Indefinite Delivery Contract (IDC) enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.
The original solicitation, expected to be issued in March 2024, seeks to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The unrestricted, fully competitive acquisition aims to make multiple regional awards, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally. The estimated total value of the contracts is $30.3 billion over a base period of 30 months and three 30-month option periods.
Task orders
Show 40 more
Latest 50 of 131 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9207?
SPE2DR25D9207 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D9207 worth?
Orders under SPE2DR25D9207 have obligated $2,359,670. SPE2DR25D9207's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9207?
131 orders have been placed under SPE2DR25D9207, the latest on July 27, 2026.
Who can order from contract SPE2DR25D9207?
SPE2DR25D9207 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9207 competed?
The extent of competition for SPE2DR25D9207 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV